PMID- 10319897 OWN - NLM STAT- MEDLINE DCOM- 19990525 LR - 20041117 IS - 0364-5134 (Print) IS - 0364-5134 (Linking) VI - 45 IP - 5 DP - 1999 May TI - Novel exon 3B proteolipid protein gene mutation causing late-onset spastic paraplegia type 2 with variable penetrance in female family members. PG - 680-3 AB - Spastic paraplegia type 2 (SPG2) is allelic to Pelizaeus-Merzbacher disease (PMD), with both conditions resulting from mutations in the proteolipid protein gene (PLP). We report an SPG2 family in which 3 male members and a heterozygous female member were affected with spastic paraplegia characterized by relatively late onset and mild clinical manifestations. A unique H147Y mutation in exon 3B of the PLP altering the proteolipid protein (PLP) but not the alternatively spliced DM20 isoform was identified as the cause of this distinct disease phenotype. Cellular pathology studies of SPG2 mutations offer an explanation for the paradoxical finding that mutations associated with the mildest phenotype in male family members also affect female carriers. FAU - Sivakumar, K AU - Sivakumar K AD - Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1361, USA. FAU - Sambuughin, N AU - Sambuughin N FAU - Selenge, B AU - Selenge B FAU - Nagle, J W AU - Nagle JW FAU - Baasanjav, D AU - Baasanjav D FAU - Hudson, L D AU - Hudson LD FAU - Goldfarb, L G AU - Goldfarb LG LA - eng PT - Journal Article PL - United States TA - Ann Neurol JT - Annals of neurology JID - 7707449 RN - 0 (Myelin Proteolipid Protein) SB - IM MH - Adolescent MH - Adult MH - Age of Onset MH - Exons MH - Female MH - Humans MH - Male MH - Mutation MH - Myelin Proteolipid Protein/*genetics MH - Pedigree MH - Phenotype MH - Spastic Paraplegia, Hereditary/*genetics MH - Time Factors EDAT- 1999/05/13 00:00 MHDA- 1999/05/13 00:01 CRDT- 1999/05/13 00:00 PHST- 1999/05/13 00:00 [pubmed] PHST- 1999/05/13 00:01 [medline] PHST- 1999/05/13 00:00 [entrez] PST - ppublish SO - Ann Neurol. 1999 May;45(5):680-3.